| Trial watch: Dendritic cell (DC)-based immunotherapy for cancer RS Laureano, J Sprooten, I Vanmeerbeerk, DM Borras, J Govaerts, ... Oncoimmunology 11 (1), 2096363, 2022 | 64 | 2022 |
| A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin JS Woodworth, HS Clemmensen, H Battey, K Dijkman, T Lindenstrøm, ... Nature Communications 12 (1), 6658, 2021 | 42 | 2021 |
| Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer J Sprooten, A Vankerckhoven, I Vanmeerbeek, DM Borras, Y Berckmans, ... Journal for Immunotherapy of Cancer 9 (11), 2021 | 28 | 2021 |
| Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer S Naulaerts, A Datsi, DM Borras, A Antoranz Martinez, J Messiaen, ... Science Translational Medicine 15 (691), eadd1016, 2023 | 18 | 2023 |
| Trial watch: chemotherapy-induced immunogenic cell death in oncology J Sprooten, RS Laureano, I Vanmeerbeek, J Govaerts, S Naulaerts, ... Oncoimmunology 12 (1), 2219591, 2023 | 17 | 2023 |
| The interface of tumour-associated macrophages with dying cancer cells in immuno-oncology I Vanmeerbeek, J Govaerts, RS Laureano, J Sprooten, S Naulaerts, ... Cells 11 (23), 3890, 2022 | 11 | 2022 |
| Single cell dynamics of tumor specificity vs bystander activity in CD8+ T cells define the diverse immune landscapes in colorectal cancer DM Borràs, S Verbandt, M Ausserhofer, G Sturm, J Lim, GA Verge, ... Cell Discovery 9 (1), 114, 2023 | 9 | 2023 |
| A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin. Nat Commun. 2021; 12: 6658 JS Woodworth, HS Clemmensen, H Battey, K Dijkman, T Lindenstrøm, ... DOI: https://doi. org/10.1038/s41467-021-26934-0, 6658, 0 | 6 | |
| A lymph node-to-tumour PDL1+macrophage circuit antagonizes dendritic cell immunotherapy J Sprooten, I Vanmeerbeek, A Datsi, J Govaerts, DM Borràs, S Naulaerts, ... bioRxiv, 2023.03. 14.532534, 2023 | 2 | 2023 |
| Lymph node and tumor-associated PD-L1+ macrophages antagonize dendritic cell vaccines by suppressing CD8+ T cells J Sprooten, I Vanmeerbeek, A Datsi, J Govaerts, S Naulaerts, ... Cell Reports Medicine 5 (1), 2024 | 1 | 2024 |
| The cell stress and immunity cycle in cancer: Toward next generation of cancer immunotherapy RS Laureano, I Vanmeerbeek, J Sprooten, J Govaerts, S Naulaerts, ... Immunological Reviews 321 (1), 71-93, 2024 | 1 | 2024 |
| 1907P Multi-omics mapping positions antigenic myeloid-T cell crosstalk at the core of advanced renal cell carcinoma (aRCC) response to immune checkpoint blockade (ICB) L Kinget, S Naulaerts, J Govaerts, I Vanmeerbeek, J Sprooten, ... Annals of Oncology 34, S1026-S1027, 2023 | | 2023 |
| A novel Mycobacterium tuberculosis-specific subunit vaccine provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin JS Woodworth, HS Clemmensen, H Battey, K Dijkman, T Lindenstrøm, ... bioRxiv, 2021.03. 18.435784, 2021 | | 2021 |
